Amphastar Pharmaceuticals, Inc.
AMPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,798,169 | $2,985,190 | $1,360,399 | $1,112,726 |
| - Cash | $151,609 | $144,296 | $156,098 | $126,353 |
| + Debt | $650,549 | $623,642 | $102,582 | $104,663 |
| Enterprise Value | $2,297,109 | $3,464,536 | $1,306,883 | $1,091,036 |
| Revenue | $731,967 | $644,395 | $498,987 | $437,768 |
| % Growth | 13.6% | 29.1% | 14% | – |
| Gross Profit | $373,855 | $351,121 | $248,860 | $199,739 |
| % Margin | 51.1% | 54.5% | 49.9% | 45.6% |
| EBITDA | $277,312 | $240,294 | $146,161 | $111,557 |
| % Margin | 37.9% | 37.3% | 29.3% | 25.5% |
| Net Income | $159,519 | $137,545 | $91,386 | $62,116 |
| % Margin | 21.8% | 21.3% | 18.3% | 14.2% |
| EPS Diluted | 3.06 | 2.6 | 1.74 | 1.25 |
| % Growth | 17.7% | 49.4% | 39.2% | – |
| Operating Cash Flow | $213,386 | $183,503 | $89,181 | $97,994 |
| Capital Expenditures | -$41,041 | -$38,166 | -$24,034 | -$27,456 |
| Free Cash Flow | $172,345 | $145,337 | $65,147 | $70,538 |